アンドロゲンを乱用する若い男性患者へのアプローチ:臨床戦略としての害の軽減

Diederik L Smit^1,2, Tijs Verdegaal^2,3, Peter Bond²

¹Department of Internal Medicine, Zaandam Medical Centre, Zaandam, the Netherlands.

The Journal of clinical endocrinology and metabolism

|September 5, 2025

まとめ

この研究は,非医療用アンドロゲン使用の管理のための臨床的枠組みを提供し,害の軽減と停止を支援することに焦点を当てています. アンドロゲン乱用を判断しないアプローチで治療する臨床医をガイドしています

科学分野:

内分泌学
スポーツ医学
臨床薬理学

背景:

非医学的なアンドロゲンの使用は,特に筋力トレーニングのコミュニティで,若い男性の間で一般的です.
臨床医はこれらの症例の管理において,未知の状況,汚名,治療の障壁などに直面しています.
アンドロゲンに関連した健康問題があり,専門医の治療が必要です.

研究の目的:

アンドロゲンを乱用する個人との接触のための臨床的枠組みを概説する.
禁煙支援と害の軽減という二重管理戦略を提案する.
アンドロゲン乱用に関連する健康リスクを最小限に抑えるための根拠に基づいた勧告を提供すること.

主な方法:

判断力のない診断と臨床的アプローチです
組織的なモニタリングと禁煙のための心理的支援
アンドロゲンの使用を止めたいという人にとっては,有害性削減戦略です.

主要な成果:

ダブルマネジメント戦略は禁煙と害の軽減の両方を効果的に扱います
テストステロン置換療法は,持続性低子腺症の 12 ヶ月間の禁断後にのみ検討されます.
害の軽減には,投与量の最適化,循環管理,心血管リスクの軽減が含まれます.

結論:

アンドロゲン乱用の管理には,禁断と害を軽減する二重アプローチが不可欠です.
この枠組みは,アンドロゲン乱用者の増加に,現実的で倫理的な対応を提供します.
患者のケアを改善するためには臨床的実践とユーザーの行動のギャップを埋めることが不可欠です

キーワード:

アナボリックステロイドアンドロゲン乱用ボディビルディング害の軽減ハイポゴナジズムテストステロンの代用療法

さらに関連する動画

08:38

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

25.4K

06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

918

関連する概念動画

01:20

Disorders of the Male Reproductive System

569

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

569

01:30

Adrenergic Agonists: Therapeutic Uses

939

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...

939

01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

01:27

Phase I Reactions: Reductive Reactions

270

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...

270

01:15

Drug Abuse and Addiction: Pharmacological Phenomena

653

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...

653

01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

関連する実験動画